3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Gynecologic
4
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Melanoma
17
Lung Neoplasms
6
Head and Neck Neoplasms
6
Pancreatic Neoplasms
5
Neoplasms
5
Colorectal Neoplasms
5
Breast Neoplasms
5
Ovarian Neoplasms
4
Kidney Neoplasms
4
Waldenstrom Macroglobulinemia
3
Stomach Neoplasms
3
Skin Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Mycosis Fungoides
3
Multiple Myeloma
3
Lymphoma, T-Cell, Cutaneous
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Mantle-Cell
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, Follicular
3
Lymphoma, B-Cell, Marginal Zone
3
Liver Neoplasms
3
Glioblastoma
3
Esophageal Neoplasms
3
Cholangiocarcinoma
3
Uterine Cervical Neoplasms
2
Sezary Syndrome
2
Sarcoma
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, Large-Cell, Anaplastic
2
Interventions
sargramostim
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
aldesleukin
1
Thrombopoietin
1
Tacrolimus
1
Specimen Handling
1
Quality of Life
1
Psychiatric Rehabilitation
1
Patient Reported Outcome Measures
1
Nivolumab
1
Moxifloxacin
1
Molecular Diagnostic Techniques
1
Methylprednisolone
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
Interleukin-12 Subunit p35
1
Interferon-alpha
1
Immunotherapy
1
Immunoenzyme Techniques
1
Ifosfamide
1
Granulocyte Colony-Stimulating Factor
1
Granisetron
1
Flow Cytometry
1
Filgrastim
1
Etoposide
1
ER 30346
1
Drug Therapy
1
Dexamethasone
1
Data Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Gestational Trophoblastic Disease
×
Drug Therapy
×
Dermatologic
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled